TGFB1 and cancer: There are and have been many ongoing clinical trials investigating the utility of various anti-TGF-β drugs for use in cancer treatment; however, despite promising preclinical studies, many of these trials fail due to lack of consistency or being unable to recapitulate the data shown in preclinical studies [49,50,51,52].